Charts

Gainers Avidity Biosciences (NASDAQ:RNA) shares rose 38.1% to $8.51 during Tuesday's pre-market session. The market value of their ...

By Thomas Kerr, CFA NASDAQ:VRAX READ THE FULL VRAX RESEARCH REPORT On September 12, 2023, Virax Biolabs (NASDAQ:VRAX) announced the launch of an early access program for research-use-only ("RUO") of its proprietary SARS-Cov-2 ViraxImmune T-cell-based test. The early access program offers select research groups an opportunity to be at the forefront of immune assessment advancements. The RUO form

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced today the launch of an early access program for the research-use-only ("RUO") of its proprietary SARS-Cov-2 ViraxImmune T-cell-based test. The company will host a webinar on September 20, 2023 at 10 AM EST.

Gainers NovaBay Pharmaceuticals (AMEX:NBY) stock rose 109.7% to $1.3 during Monday's pre-market session. The company's market cap ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Friday's session saw 225 companies set new 52-week lows. Significant Points From Today's 52-Week ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced today the appointment of Dr. Nigel McCracken as the Company's Chief Operating Officer ("COO"). Dr. McCracken will succeed Mr. Cameron Shaw, who is moving to Virax's Advisory Board, and will lead the Company's various growth initiatives, including the Company's expected near-term research-use-only launch of

Gainers NuCana (NASDAQ:NCNA) stock rose 17.3% to $0.84 during Friday's after-market session. This security traded at a volume of 164.1K ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ballard Power Systems (BLDP) stock is getting a boost on Thursday after announcing a partnership with Ford (F) for hydrogen fuel cell tech. The post Why Is Ballard Power (BLDP) Stock Up 7% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sunrun (RUN) stock is taking off on Thursday alongside earnings and a new price prediction from Janney Montgomery Scott analyst Thomas Meric. The post RUN Stock Price Prediction: Can Sunrun Really Rally 80% From Here? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virax Biolabs (VRAX) stock is on the rise Thursday as investors react to the news on an extension from the Nasdaq Exchange. The post Why Is Virax Biolabs (VRAX) Stock Up Today? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Name for 2023 Could Be About to Ignite This $20.6 Trillion Wealth Shift Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The $1 Investment You MUST Take Advantage of Right Now The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced today that Nasdaq has approved the Company's request for a 180-day extension to meet the $1 minimum bid price requirement.

Gainers Etao International Co (NASDAQ:ETAO) shares rose 10.3% to $0.48 during Tuesday's after-market session. The market value of their ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced today that it has signed contracts to launch two new research and laboratory facilities in the United Kingdom.

By Thomas Kerr, CFA NASDAQ:VRAX READ THE FULL VRAX RESEARCH REPORT On June 14th, 2023, Virax Biolabs (NASDAQ:VRAX) released a shareholder letter from CEO James Foster and also filed its 20-F annual report that provided financial results for the fiscal year ending March 31, 2023. The CEO updated the investor community on recent developments at Virax and disclosed for the first time a comprehensive

Gainers Blue Water Biotech (NASDAQ:BWV) shares increased by 61.4% to $1.27 during Wednesday's regular session. Trading volume for Blue ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced that Mr. James Foster, Chairman of the Board & Chief Executive Officer of Virax, has issued a letter to shareholders.

Gainers Lucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 34.2% to $1.45 during Friday's pre-market session. The market ...

By Thomas Kerr, CFA NASDAQ:VRAX READ THE FULL VRAX RESEARCH REPORT Virax Biolabs Group Limited (NASDAQ:VRAX) has made recent announcements regarding business operations and capital financing, as well as an updated investor presentation. New Regional Headquarters On May 4th, 2023, the company announced that it established a regional headquarters at Dubai Science Park, a member of TECOM Group PJSC.

On Thursday, 498 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Pfizer ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune responses to and diagnosis of viral diseases, announced today that it established a regional headquarters at Dubai Science Park, a member of TECOM Group PJSC.

Gainers Augmedix (NASDAQ:AUGX) shares rose 69.5% to $3.05 during Thursday's regular session. As of 13:30 EST, Augmedix's stock is ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rivian Automotive (RIVN) stock is a hot topic on Wednesday after getting its price target cut in half by RBC Capital Markets. The post RIVN Stock Alert: RBC Just Slashed Its Rivian Price Target in Half appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Wall Street Titan: Here’s My #1 Stock for 2023 It doesn’t matter if you have $500 or $5 million. Do this now.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virax Biolabs (VRAX) stock is on the rise Wednesday after the company secured a Marburg Virus Real Time PCR Kit distribution deal. The post Virax Biolabs (VRAX) Stock Soars on PCR Test DIstribution Agreement appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Wall Street Titan: Here’s My #1 Stock for 2023 It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 34.2% to $0.81 during Wednesday's pre-market session. The market value of their ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotech company focused on the detection of immune responses to and diagnosis of viral diseases, announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today the closing of its previously announced private placement of 3,843,309 ordinary shares (or ordinary share equivalents), Series A preferred investment options to purchase up to an aggregate of 3,497,412 ordinary shares and Series B preferred investment options to purchase up to an aggregate of 3,843,309 or

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today that it has entered into definitive agreements for the purchase and sale of 3,843,309 ordinary shares (or ordinary share equivalents), Series A preferred investment options to purchase up to an aggregate of 3,497,412 ordinary shares and Series B preferred investment options to purchase up to an aggregate

Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 450 points on Tuesday. The Dow traded down ...

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the ...

Gainers Virax Biolabs Group (NASDAQ:VRAX) stock moved upwards by 118.6% to $1.45 during Tuesday's regular session. The current volume ...

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday. The Dow traded down 0.77% ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virax Biolabs just announced a new testing kit for a potentially deadly disease in Europe, and VRAX stock traders are on a buying spree. The post Why Is Virax Biolabs (VRAX) Stock Up 100% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It

Virax Biolabs Group Ltd (NASDAQ: VRAX) shares are trading higher on abnormally high volume Tuesday after the company announced an ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced today that it has entered into an agreement for the distribution of an Avian Influenza A Virus ("AIV") real-time PCR test kit to markets accepting the CE mark, namely the European Union. The test kit is for the detection and differentiation of ribonucleic acid from AIV and the H5, H7 and H9 subtypes, including th

Virax Biolabs Group Limited (NASDAQ: VRAX) has announced the distribution of an Avian Influenza A Virus real-time PCR test kit to the ...

By Thomas Kerr, CFA NASDAQ:VRAX READ THE FULL VRAX RESEARCH REPORT Virax Biolabs (NASDAQ:VRAX) is an innovative biotechnology company focused on the detection and diagnosis of viral diseases. Virax Biolabs believes it is developing a game-changing immunology platform called Virax Immune that is based around proprietary T-Cell testing technology which is anticipated to be effective in the

Gainers Janux Therapeutics (NASDAQ:JANX) stock moved upwards by 27.8% to $22.83 during Thursday's after-market session. The market ...

New York City is ending its COVID vaccine mandate for public-sector workers this week, including police officers, firefighters and teachers.

CHICAGO, IL / ACCESSWIRE / February 7, 2023 / Cosmos Health Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, is pleased to announce the first purchase order to market and distribute Virax Biolabs' (Nasdaq: VRAX) ViraxClear branded COVID-19 and Influenza A+B Antigen Combo Rapid Detection Kits. Pursuant to its previously signed distribution agreement dated September 2022, Cosmos Health will have exclusive distribution rights for Greece and Cyprus, with the opportunity to distribute the ViraxClear branded test kits across Europe on a non-exclusive basis.

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced that it has signed a Purchase Order with Cosmos Health (Nasdaq: COSM) ("Cosmos") to launch and market COVID-19 and Influenza A+B Antigen Combo Rapid Detection Kits. Pursuant to their previously signed distribution agreement dated September 2022, Cosmos will have exclusive distribution rights for Greece and Cyprus

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, today announced that Dr. Tomasz George, Chief Scientific Officer of Virax, and Cameron Shaw, Chief Operations Officer at Virax, will be presenting at the BIO CEO & Investor Conference on Tuesday, February 7, 2023.

Gainers Nymox Pharmaceutical (NASDAQ:NYMX) shares rose 21.8% to $0.5 during Monday's after-market session. The market value of their ...

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has ...

Virax Biolabs ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today the distribution of HPV test kits with shipments anticipated in Q1 of 2023 to markets accepting the CE mark, such as the European Union. The test kit covers 18 different genotypes of HPV, including type 53, which is higher risk and becoming increasingly prevalent. The specialized diagnostic kits can be found by contact

Virax Biolabs Group Ltd(NASDAQ: VRAX) has announced the distribution of HPV test kits with shipments anticipated in Q1 of 2023 to ...

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a ...

In this article, we discuss the 10 biotech stocks with the biggest upside. If you want to read about some more biotech stocks with the biggest upside, go directly to 5 Biotech Stocks With The Biggest Upside. The biotechnology sector has been one of the most profitable growth spaces in the stock market over the […]

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG ...

Wednesday saw 219 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest ...

Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) stock rose 50.0% to $2.19 during Friday's regular session. Shuttle Pharmaceuticals's ...